81
Views
8
CrossRef citations to date
0
Altmetric
Original Research

CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation

, , , , , , , & show all
Pages 497-504 | Published online: 29 Mar 2018

References

  • MozaffarianDBenjaminEJGoASHeart disease and stroke statistics–2015 update: a report from the American Heart AssociationCirculation20151314e29e32225520374
  • CammAJLipGYDe CaterinaR2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm AssociationEuropace201214101385141322923145
  • LipGYLinHJChienKLComparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort StudyInt J Cardiol2013168141441923073283
  • MitchellLBSouthernDAGalbraithDGhaliWAKnudtsonMWiltonSBAPPROACH investigatorsPrediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scoresHeart2014100191524153024860007
  • PolenzGFLeiriaTLEssebagVCHA2DS2-VASc score as a predictor of cardiovascular events in ambulatory patients without atrial fibrillationPacing Clin Electrophysiol201538121412141726310935
  • XingYMaQMaXWangCZhangDSunYCHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillationClin Interv Aging20161194194627478371
  • XingYLMaQMaXYCharacteristics of non-valvular atrial fibrillation patients who benefit most from anticoagulation treatmentInt J Clin Exp Med2015810187211872826770487
  • LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillationChest2010137226327219762550
  • MazzaAPessinaACPaveiAScarpaRTikhonoffVCasigliaEPredictors of stroke mortality in elderly people from the general population. The Cardiovascular Study in the ElderlyEur J Epidemiol200117121097110412530768
  • ChanYHYiuKHLauKKThe CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongationAtherosclerosis2014237250451325463082
  • LaiHCChienWCChungCHAtrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: a population-based cohort studyInt J Cardiol201519713313926126057
  • KimKHKimWHwangSHThe CHA2DS2-VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillationJ Cardiol201565212112724972564
  • SantosaFNowakTMoysidisTCHADS2 and CHA2DS2Vasc-Score in Peripheral Systemic EmbolismJ Atr Fibrillation20136171528496847
  • PegueroJGIssaOPodestaCElmahdyHMSantanaOLamasGAUsefulness of the CHA2DS2VASc score to predict postoperative stroke in patients having cardiac surgery independent of atrial fibrillationAm J Cardiol2015115675876225616533
  • PodoleckiTLenarczykRKowalczykJStroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillationJ Cardiovasc Med (Hagerstown)201516749750225829193
  • MelgaardLGorst-RasmussenALaneDARasmussenLHLarsenTBLipGYAssessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillationJAMA2015314101030103826318604
  • CushmanMPsatyBMMacyECorrelates of thrombin markers in an elderly cohort free of clinical cardiovascular diseaseArterioscler Thromb Vasc Biol1996169116311698792770
  • ChongAYLipGYViewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?Eur J Heart Fail20079212412816859990
  • ChaJKLimJHKimDHPrognostic factors for long-term poor outcomes after acute ischemic stroke in very old age (>80 years) patients: total cholesterol level might differently influence long-term outcomes after acute ischemic stroke at ages above 80 yearsGeriatr Gerontol Int201515111227123325496005
  • YuanZMakadiaRRyanPYannicelliDNesselCSarichTIncidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort studyCurr Med Res Opin20153171257126625877807
  • PattiGLucernaMPecenLThromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)J Am Heart Assoc201767e00565728736385
  • ElgendyAYMahttaDBarakatAFMeta-analysis of safety and efficacy of uninterrupted non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists for catheter ablation of atrial fibrillationAm J Cardiol201712010s1830183628882334
  • OdutayoAWongCXHsiaoAJHopewellSAltmanDGEmdinCAAtrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysisBMJ2016354i448227599725
  • Clua-EspunyJLPanisello-TafallaALopez-PabloCAtrial fibrillation and cardiovascular comorbidities, survival and mortality: a real-life observational studyCardiol Res201451122228392870
  • LiLHShengCSHuBCThe prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective studyBMC Cardiovascular Disorders2015153125953603
  • SaadMarwanIslamYElgendyIncidence, predictors, and outcomes of early atrial arrhythmias after lung transplant: a systematic review and meta-analysisJ Am Coll Cardiol EP20173718726
  • MahmoudANAl-AniMSaadMElgendyAYElgendyIYDevelopment and validation of a simple integer risk score for prediction of in-hospital mortality following Takotsubo syndromeHeart Lung201645651051427679934